Which Factors Will Push The Radio Frequency Identification (RFID) In Pharmaceuticals Market To Achieve $9.12 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market In The Coming Years?
In recent times, there has been significant growth in the market size of radio frequency identification (RFID) in pharmaceuticals. The market which was worth $5.48 billion in 2024 is projected to escalate to a value of $6.08 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The historic period saw this growth majorly due to increased pharmaceutical exports, a surge in e-commerce, an upward trend in clinical trials, a growing need for tamper-evident RFID solutions, and a rise in patient-focused healthcare delivery models.
Expectations are high for swift expansion in the upcoming years for the radio frequency identification (RFID) in pharmaceuticals market, with projections forecasting a market value of $9.12 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period is attributed to a rise in counterfeit drug incidents, increased consciousness about healthcare, expanding hospital automation, a growing requirement for real-time tracking, and a boost in investments for digital supply chain solutions. The forecast period will likely see significant trends such as technological evolution, improvements in radio frequency identification tag design, fusion with cloud-based platforms, progression in pharmaceutical-specific inlays, and enhancements in supply chain digitalization.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp
Which Growth Drivers Are Shaping The Radio Frequency Identification (RFID) In Pharmaceuticals Market Outlook?
The surge in instances of fake medications is anticipated to fuel the expansion of the radio frequency identification (RFID) within the pharmaceuticals market. Counterfeit drugs, also known as spurious medicines, are medications that are deceptively mislabeled regarding their source or identity. This rise in counterfeit drugs is due to the swift expansion of internet pharmacies that have simplified the distribution of fraudulent drugs straight to customers, thereby eluding conventional regulatory checks and escalating detection challenges. The use of radio frequency identification (RFID) in pharmaceuticals enables the battle against fake drugs by offering secure, traceable information confirming product genuineness at every step of the supply chain. For instance, according to recent reports from the American Chemical Society, a US-based nonprofit scientific society, there were 6,987 recorded counterfeit drug episodes across 142 countries in 2023, which is a 4% increase from 2022. Consequently, the surge in counterfeit drug instances is stimulating the expansion of the radio frequency identification (RFID) in the pharmaceuticals market.
What Is The Segment Breakdown Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?
The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –
1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification
2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software
3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations
4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications
5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies
Subsegments:
1) By Chipped Radio Frequency Identification, By Type: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification
2) By Chipless Radio Frequency Identification, By Type: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures
How Are Global Trends Impacting The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?
Key players in the pharmaceutical radio frequency identification (RFID) market are concentrating on creating advanced RFID-integrated labels to amplify product visibility, bolster inventory control, and tackle the escalating issue of counterfeit medications. These RFID-integrated labels, also known as smart tags, employ radio frequency technology to wirelessly recognize, monitor, and authenticate pharmaceutical items throughout the distribution chain. For example, in May 2023, Germany’s Fresenius Kabi AG, a pharmaceutical hulk initiated the Rocuronium Bromide Injection outfitted with advanced RFID-embedded labeling in order to augment medicine tracking, inventory regulation, and patient safety in medical institutions. This injection is disseminated as a 50 mg per 5 mL multiple-dose vial for intravenous use by certified medical practitioners. The inclusion of advanced RFID-integrated smart labels facilitates real-time monitoring, simplifies inventory control, and minimizes medication discrepancies.
Who Are The Major Stakeholders Operating In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?
Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?
North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp
Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2025, By The Business Research Company
Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Therapeutic Drug Monitoring Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report
Pharmaceutical Label Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
